113 related articles for article (PubMed ID: 9806485)
41. Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative.
Li Y; Fu L; Yeo H; Zhu JL; Chou CK; Kou YH; Yeh SF; Gullen E; Austin D; Cheng YC
Antivir Chem Chemother; 2005; 16(3):193-201. PubMed ID: 16004082
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
[TBL] [Abstract][Full Text] [Related]
43. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro.
Jung J; Kim NK; Park S; Shin HJ; Hwang SG; Kim K
BMC Complement Altern Med; 2015 Jul; 15():255. PubMed ID: 26220282
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.
Xu B; Huang Z; Liu C; Cai Z; Pan W; Cao P; Hao X; Liang G
Bioorg Med Chem; 2009 Apr; 17(8):3118-25. PubMed ID: 19307124
[TBL] [Abstract][Full Text] [Related]
46. Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
Zhang M; Wu X; Lai F; Zhang X; Wu H; Min T
J Agric Food Chem; 2016 May; 64(20):4068-77. PubMed ID: 27144395
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.
Parvez MK; Sehgal D; Sarin SK; Basir SF; Jameel S
World J Gastroenterol; 2006 May; 12(19):3006-14. PubMed ID: 16718779
[TBL] [Abstract][Full Text] [Related]
48. Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells.
Sood RK; Bhadti VS; Fattom AI; Naso RB; Korba BE; Kern ER; Chen HM; Hosmane RS
Antiviral Res; 2002 Feb; 53(2):159-64. PubMed ID: 11750942
[TBL] [Abstract][Full Text] [Related]
49. Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional Chinese medicine: Rhizomes of Cyperus rotundus.
Xu HB; Ma YB; Huang XY; Geng CA; Wang H; Zhao Y; Yang TH; Chen XL; Yang CY; Zhang XM; Chen JJ
J Ethnopharmacol; 2015 Aug; 171():131-40. PubMed ID: 26051832
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B virus resistance to lamivudine and its clinical implications.
Liu X; Schinazi RF
Antivir Chem Chemother; 2002 May; 13(3):143-55. PubMed ID: 12448687
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
Zoulim F
Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
[TBL] [Abstract][Full Text] [Related]
52. In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B viruses.
Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL; Csizmadia F
Antiviral Res; 1997 May; 34(3):75-90. PubMed ID: 9191015
[TBL] [Abstract][Full Text] [Related]
53. Experience with lamivudine against hepatitis B virus.
Jaeckel E; Manns MP
Intervirology; 1997; 40(5-6):322-36. PubMed ID: 9675637
[TBL] [Abstract][Full Text] [Related]
54. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.
Korba BE; Montero AB; Farrar K; Gaye K; Mukerjee S; Ayers MS; Rossignol JF
Antiviral Res; 2008 Jan; 77(1):56-63. PubMed ID: 17888524
[TBL] [Abstract][Full Text] [Related]
55. Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAi.
Teng X; Xu WZ; Hao ML; Fang Y; Zhao YX; Chen SJ; Li D; Gu HX
J Virol Methods; 2010 Sep; 168(1-2):6-12. PubMed ID: 20403386
[TBL] [Abstract][Full Text] [Related]
56. Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.
Ono-Nita SK; Kato N; Shiratori Y; Lan KH; Yoshida H; Carrilho FJ; Omata M
J Clin Invest; 1999 Jun; 103(12):1635-40. PubMed ID: 10377169
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and in-vitro anti-hepatitis-B virus activity of 6H-[1]benzothiopyrano[4,3-b] quinolin-10-ols.
Jia W; Zhao Y; Li R; Wu Y; Li Z; Gong P
Arch Pharm (Weinheim); 2009 Sep; 342(9):507-12. PubMed ID: 19637181
[TBL] [Abstract][Full Text] [Related]
58. The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues.
Ladner SK; Miller TJ; Otto MJ; King RW
Antivir Chem Chemother; 1998 Jan; 9(1):65-72. PubMed ID: 9875378
[TBL] [Abstract][Full Text] [Related]
59. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.
Xun YH; Zhang YJ; Pan QC; Mao RC; Qin YL; Liu HY; Zhang YM; Yu YS; Tang ZH; Lu MJ; Zang GQ; Zhang JM
J Viral Hepat; 2014 Aug; 21(8):597-603. PubMed ID: 24164660
[TBL] [Abstract][Full Text] [Related]
60. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
